Autor: |
Chen, Muwan, Maimaitili, Muyesier, Buchholdt, Susanne Hvolbøl, Jensen, Uffe Birk, Febbraro, Fabia, Denham, Mark |
Zdroj: |
Stem Cell Research; May2020, Vol. 45, pN.PAG-N.PAG, 1p |
Abstrakt: |
We generated an induced pluripotent stem cell (iPSC) line from fibroblasts of a clinically diagnosed 70 year old female Parkinson's disease (PD) patient heterozygous for a pathogenic missense variant (p.G2019S; c. 6055 G > A) in the leucine-rich repeat kinase 2 (LRRK2) gene by using non-integrating Sendai viruses. The DANi-011A iPSC line has a normal karyotype and is free from Sendai viruses. The expression of pluripotent markers in the iPSC line was confirmed by immunofluorescent staining, and we confirmed its ability to differentiate into the three germ layers. The DANi-011A iPSC line can be used for modeling PD and as a drug-screening platform. [ABSTRACT FROM AUTHOR] |
Databáze: |
Supplemental Index |
Externí odkaz: |
|